Table 4.
CRS Patient Isolates, Number | CRS Isolates, Percent | Control Isolates, Number | Control Isolates, Percent | |
---|---|---|---|---|
mecA * | 0 | 0.0 | 1 | 2.0 |
SCCmec Iva * | 0 | 0.0 | 1 | 2.0 |
mecC | 0 | 0.0 | 0 | 0.0 |
blaZ | 29 | 56.9 | 37 | 75.5 |
erm(A) | 3 | 5.9 | 3 | 6.1 |
erm(B), erm(C), lnu(A), msrA | 0 | 0.0 | 0 | 0.0 |
aacA-aphD | 0 | 0.0 | 1 | 2.0 |
aadD, aphA3, sat | 0 | 0.0 | 0 | 0.0 |
fusC, far1 | 0 | 0.0 | 0 | 0.0 |
tet(K) | 0 | 0.0 | 3 | 6.1 |
dfrA, mupR, tet(M), cat, cfr, fexA, van genes | 0 | 0.0 | 0 | 0.0 |
qacC | 1 | 2.0 | 0 | 0.0 |
* in a CC30-MRSA-IV (PVL-/tst1-).